Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Life Science Analytics | Respiratory and Pulmonary System Pulmonary Hypertension Therapy Area Pipeline Report

Respiratory and Pulmonary System Pulmonary Hypertension Therapy Area Pipeline Report

Life Science Analytics', Pulmonary Hypertension Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of pulmonary hypertension drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics? Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company?s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

? Understand a company?s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.

? Keep track of your competitors and partners by better understanding their product pipeline.

? Monitor a company?s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.

? Maintain a critical competitive advantage.

Publication 30th July 2009 then monthly,Format PDF Pages: 306 Epidemiology Report

% of Products by Phase of Development

No. of Products by Phase of Development

Marketed Products vs. Pipeline Products

Company Overview - Pipeline Projects

Legend

--Top 5 Companies in Early Stage Pulmonary Hypertension Products

--Top 5 Companies in Late Stage Pulmonary Hypertension Products

--Top 5 Companies in Marketed Pulmonary Hypertension Products

Patent Expirations

Upcoming Milestones

Product Sales

Full Pipeline View

--Product Details : Unknown/Research

--Product Details : Pre Clinical

--Product Details : Phase I

--Product Details : Phase II

--Product Details : Phase III

--Product Details : Pending Approval

--Product Details : On the Market

--Product Details : Post Marketing

News Updates

--Product Updates

--Regulatory

Description
Price: $1,495.00 / €999.26

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions